← United States · Coverage record
US · SEC FORM 4
Werewolf Therapeutics, Inc.
HOWL · Nasdaq · CIK 0001785530 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
52 Form 4 transaction lines observed in the same window
52 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-05-14 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 2,511,400
- Previous report
- 1,705,956
- Avg daily volume
- 679,291
- Days to cover
- 3.7
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-05-14 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. | Purchase (P) | Common Stock | 162,539 | USD 0.98 | USD 159,288 | SEC filing ↗ |
| 2025-05-13 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. | Purchase (P) | Common Stock | 52,974 | USD 0.98 | USD 51,915 | SEC filing ↗ |
| 2025-05-12 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. | Purchase (P) | Common Stock | 320,913 | USD 0.86 | USD 275,985 | SEC filing ↗ |
| 2023-01-06 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Purchase (P) | Common Stock | 1,853,000 | USD 2.21 | USD 4,095,130 | SEC filing ↗ |
| 2021-06-16 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Purchase (P) | Common Stock | 9,285 | USD 13.37 | USD 124,140 | SEC filing ↗ |
| 2021-06-15 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Purchase (P) | Common Stock | 7,958 | USD 12.95 | USD 103,056 | SEC filing ↗ |
| 2021-06-14 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Purchase (P) | Common Stock | 306,055 | USD 12.75 | USD 3,902,201 | SEC filing ↗ |
| 2021-05-04 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Purchase (P) | Common Stock | 1,715,000 | USD 16.00 | USD 27,440,000 | SEC filing ↗ |
| 2021-05-04 | GADICKE ANSBERT; MPM ONCOLOGY INNOVATIONS FUND LP; MPM Oncology Impact Management GP LLC; MPM Oncology Impact Management LP; MPM Oncology Innovations Fund GP LLC; Oncology Impact Fund (Cayman) Management L.P.; UBS Oncology Impact Fund L.P. | Purchase (P) | Common Stock | 245,000 | USD 16.00 | USD 3,920,000 | SEC filing ↗ |
| 2021-05-04 | Foley Todd; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P. | Purchase (P) | Common Stock | 125,759 | USD 16.00 | USD 2,012,144 | SEC filing ↗ |
| 2021-05-04 | EVNIN LUKE | Purchase (P) | Common Stock | 150,799 | USD 16.00 | USD 2,412,784 | SEC filing ↗ |
| 2021-05-04 | Taiho Ventures LLC | Purchase (P) | Common Stock | 312,500 | USD 16.00 | USD 5,000,000 | SEC filing ↗ |
| 2021-05-04 | SPHERA FUNDS MANAGEMENT LTD.; Sphera Global Healthcare GP Ltd.; Sphera Global Healthcare Management LP | Purchase (P) | Common Stock | 475,000 | USD 16.00 | USD 7,600,000 | SEC filing ↗ |
| 2021-05-04 | Longwood Fund III GP, LLC; Longwood Fund III, L.P. | Purchase (P) | Common Stock | 250,000 | USD 16.00 | USD 4,000,000 | SEC filing ↗ |
| 2021-05-04 | Lazarus Alon | Purchase (P) | Common Stock | 400,000 | USD 16.00 | USD 6,400,000 | SEC filing ↗ |
Form 4 evidence
163 transaction lines in the latest 365-day window; 216 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | EVNIN LUKE | Sale (S) | Common Stock | 107,429 | USD 0.31 | USD 33,303 | SEC filing ↗ |
| 2026-07-06 | EVNIN LUKE | Sale (S) | Common Stock | 35,770 | USD 0.32 | USD 11,446 | SEC filing ↗ |
| 2026-06-29 | EVNIN LUKE | Sale (S) | Common Stock | 157,084 | USD 0.30 | USD 47,125 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | EVNIN LUKE | Sale (S) | Common Stock | 107,429 | USD 0.31 | USD 33,303 | SEC filing ↗ |
| 2026-07-06 | EVNIN LUKE | Sale (S) | Common Stock | 35,770 | USD 0.32 | USD 11,446 | SEC filing ↗ |
| 2026-06-29 | EVNIN LUKE | Sale (S) | Common Stock | 157,084 | USD 0.30 | USD 47,125 | SEC filing ↗ |
| 2026-06-17 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 416,911 | USD 0.35 | USD 145,919 | SEC filing ↗ |
| 2026-06-16 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 149,625 | USD 0.37 | USD 55,361 | SEC filing ↗ |
| 2026-06-15 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 128,770 | USD 0.39 | USD 50,220 | SEC filing ↗ |
| 2026-06-12 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 170,441 | USD 0.40 | USD 68,176 | SEC filing ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 262,503 | USD 0.38 | USD 99,751 | SEC filing ↗ |
| 2026-06-10 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 45,923 | USD 0.37 | USD 16,992 | SEC filing ↗ |
| 2026-06-09 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 369,800 | USD 0.37 | USD 136,826 | SEC filing ↗ |
| 2026-06-09 | EVNIN LUKE | Sale (S) | Common Stock | 76,928 | USD 0.37 | USD 28,463 | SEC filing ↗ |
| 2026-06-08 | EVNIN LUKE | Sale (S) | Common Stock | 60,547 | USD 0.40 | USD 24,219 | SEC filing ↗ |
| 2026-06-05 | EVNIN LUKE | Sale (S) | Common Stock | 24,946 | USD 0.40 | USD 9,978 | SEC filing ↗ |
| 2026-06-04 | EVNIN LUKE | Sale (S) | Common Stock | 20,072 | USD 0.44 | USD 8,832 | SEC filing ↗ |
| 2026-06-03 | EVNIN LUKE | Sale (S) | Common Stock | 29,749 | USD 0.42 | USD 12,495 | SEC filing ↗ |
| 2026-06-02 | EVNIN LUKE | Sale (S) | Common Stock | 29,595 | USD 0.45 | USD 13,318 | SEC filing ↗ |
| 2026-06-01 | EVNIN LUKE | Sale (S) | Common Stock | 80,459 | USD 0.47 | USD 37,816 | SEC filing ↗ |
| 2026-05-29 | EVNIN LUKE | Sale (S) | Common Stock | 32,556 | USD 0.45 | USD 14,650 | SEC filing ↗ |
| 2026-05-28 | EVNIN LUKE | Sale (S) | Common Stock | 27,698 | USD 0.46 | USD 12,741 | SEC filing ↗ |
| 2026-05-27 | EVNIN LUKE | Sale (S) | Common Stock | 80,852 | USD 0.48 | USD 38,809 | SEC filing ↗ |
| 2026-05-26 | EVNIN LUKE | Sale (S) | Common Stock | 67,950 | USD 0.47 | USD 31,936 | SEC filing ↗ |
| 2026-05-22 | EVNIN LUKE | Sale (S) | Common Stock | 87,425 | USD 0.45 | USD 39,341 | SEC filing ↗ |
| 2026-05-21 | EVNIN LUKE | Sale (S) | Common Stock | 36,387 | USD 0.42 | USD 15,283 | SEC filing ↗ |
| 2026-05-20 | EVNIN LUKE | Sale (S) | Common Stock | 85,895 | USD 0.43 | USD 36,935 | SEC filing ↗ |
| 2026-05-19 | EVNIN LUKE | Sale (S) | Common Stock | 62,970 | USD 0.45 | USD 28,336 | SEC filing ↗ |
| 2026-05-18 | EVNIN LUKE | Sale (S) | Common Stock | 22,184 | USD 0.50 | USD 11,092 | SEC filing ↗ |
| 2026-05-13 | EVNIN LUKE | Sale (S) | Common Stock | 44,679 | USD 0.54 | USD 24,127 | SEC filing ↗ |
| 2026-05-12 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 101,151 | USD 0.64 | USD 64,737 | SEC filing ↗ |
| 2026-05-12 | EVNIN LUKE | Sale (S) | Common Stock | 67,885 | USD 0.64 | USD 43,446 | SEC filing ↗ |
| 2026-05-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | Sale (S) | Common Stock | 87,490 | USD 0.67 | USD 58,618 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | HOWL |
| CIK | 0001785530 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 216 transaction lines from 2021-05-04 to 2026-07-07 19 P purchase lines · 168 S sale lines · 29 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.